Literature DB >> 26048987

Deciphering the BRCA1 Tumor Suppressor Network.

Qinqin Jiang1, Roger A Greenberg2.   

Abstract

The BRCA1 tumor suppressor protein is a central constituent of several distinct macromolecular protein complexes that execute homology-directed DNA damage repair and cell cycle checkpoints. Recent years have borne witness to an exciting phase of discovery at the basic molecular level for how this network of DNA repair proteins acts to maintain genome stability and suppress cancer. The clinical dividends of this investment are now being realized with the approval of first-in-class BRCA-targeted therapies for ovarian cancer and identification of molecular events that determine responsiveness to these agents. Further delineation of the basic science underlying BRCA network function holds promise to maximally exploit genome instability for hereditary and sporadic cancer therapy.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  BRCA1; BRCA2; DNA damage response; DNA repair; breast cancer

Mesh:

Substances:

Year:  2015        PMID: 26048987      PMCID: PMC4505021          DOI: 10.1074/jbc.R115.667931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

1.  RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage.

Authors:  Marco Gatti; Sabrina Pinato; Alessio Maiolica; Francesca Rocchio; Maria Giulia Prato; Ruedi Aebersold; Lorenza Penengo
Journal:  Cell Rep       Date:  2015-01-08       Impact factor: 9.423

2.  MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling.

Authors:  Krasimira Rozenova; Jing Jiang; Ryan Donaghy; Bernadette Aressy; Roger A Greenberg; Wei Tong
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

3.  The BRCA1-interacting protein Abraxas is required for genomic stability and tumor suppression.

Authors:  Andy Castillo; Atanu Paul; Baohua Sun; Ting Hsiang Huang; Yucai Wang; Stephanie A Yazinski; Jessica Tyler; Lei Li; M James You; Lee Zou; Jun Yao; Bin Wang
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

4.  BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork.

Authors:  David T Long; Vladimir Joukov; Magda Budzowska; Johannes C Walter
Journal:  Mol Cell       Date:  2014-09-11       Impact factor: 17.970

5.  Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

Authors:  Hikmat Al-Ahmadie; Gopa Iyer; Marcel Hohl; Saurabh Asthana; Akiko Inagaki; Nikolaus Schultz; Aphrothiti J Hanrahan; Sasinya N Scott; A Rose Brannon; Gregory C McDermott; Mono Pirun; Irina Ostrovnaya; Philip Kim; Nicholas D Socci; Agnes Viale; Gary K Schwartz; Victor Reuter; Bernard H Bochner; Jonathan E Rosenberg; Dean F Bajorin; Michael F Berger; John H J Petrini; David B Solit; Barry S Taylor
Journal:  Cancer Discov       Date:  2014-06-16       Impact factor: 39.397

6.  Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice.

Authors:  Srilatha Simhadri; Shaun Peterson; Dharm S Patel; Yanying Huo; Hong Cai; Christian Bowman-Colin; Shoreh Miller; Thomas Ludwig; Shridar Ganesan; Mantu Bhaumik; Samuel F Bunting; Maria Jasin; Bing Xia
Journal:  J Biol Chem       Date:  2014-07-11       Impact factor: 5.157

7.  Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome.

Authors:  Robert K McGinty; Ryan C Henrici; Song Tan
Journal:  Nature       Date:  2014-10-30       Impact factor: 49.962

8.  Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage.

Authors:  Sarah J Hill; Thomas Rolland; Guillaume Adelmant; Xianfang Xia; Matthew S Owen; Amélie Dricot; Travis I Zack; Nidhi Sahni; Yves Jacob; Tong Hao; Kristine M McKinney; Allison P Clark; Deepak Reyon; Shengdar Q Tsai; J Keith Joung; Rameen Beroukhim; Jarrod A Marto; Marc Vidal; Suzanne Gaudet; David E Hill; David M Livingston
Journal:  Genes Dev       Date:  2014-09-01       Impact factor: 11.361

9.  Mechanism of suppression of chromosomal instability by DNA polymerase POLQ.

Authors:  Matthew J Yousefzadeh; David W Wyatt; Kei-Ichi Takata; Yunxiang Mu; Sean C Hensley; Junya Tomida; Göran O Bylund; Sylvie Doublié; Erik Johansson; Dale A Ramsden; Kevin M McBride; Richard D Wood
Journal:  PLoS Genet       Date:  2014-10-02       Impact factor: 5.917

10.  BRCA1 is a histone-H2A-specific ubiquitin ligase.

Authors:  Reinhard Kalb; Donna L Mallery; Conor Larkin; Jeffrey T J Huang; Kevin Hiom
Journal:  Cell Rep       Date:  2014-08-14       Impact factor: 9.423

View more
  35 in total

1.  The Lys63-deubiquitylating Enzyme BRCC36 Limits DNA Break Processing and Repair.

Authors:  Hoi-Man Ng; Leizhen Wei; Li Lan; Michael S Y Huen
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

2.  Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.

Authors:  Ruth M Densham; Alexander J Garvin; Helen R Stone; Joanna Strachan; Robert A Baldock; Manuel Daza-Martin; Alice Fletcher; Sarah Blair-Reid; James Beesley; Balraj Johal; Laurence H Pearl; Robert Neely; Nicholas H Keep; Felicity Z Watts; Joanna R Morris
Journal:  Nat Struct Mol Biol       Date:  2016-05-30       Impact factor: 15.369

3.  BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites.

Authors:  Zhaohua Hu; Shaojie Mi; Ting Zhao; Changmin Peng; Yihan Peng; Lulu Chen; Wenge Zhu; Yi Yao; Qibin Song; Xiangpan Li; Xinzhi Li; Chenxi Jia; Huadong Pei
Journal:  EMBO J       Date:  2020-04-29       Impact factor: 11.598

4.  p97 Promotes a Conserved Mechanism of Helicase Unloading during DNA Cross-Link Repair.

Authors:  George Fullbright; Halley B Rycenga; Jordon D Gruber; David T Long
Journal:  Mol Cell Biol       Date:  2016-11-14       Impact factor: 4.272

5.  Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation.

Authors:  Violeta Régnier Galvão; Elizabeth Phillips; Pedro Giavina-Bianchi; Mariana C Castells
Journal:  J Allergy Clin Immunol Pract       Date:  2016-10-17

Review 6.  Small-Molecule Inhibitors Targeting DNA Repair and DNA Repair Deficiency in Research and Cancer Therapy.

Authors:  Sarah R Hengel; M Ashley Spies; Maria Spies
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

7.  RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance.

Authors:  Yifan Wang; John J Krais; Andrea J Bernhardy; Emmanuelle Nicolas; Kathy Q Cai; Maria I Harrell; Hyoung H Kim; Erin George; Elizabeth M Swisher; Fiona Simpkins; Neil Johnson
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

Review 8.  Hereditary breast and ovarian cancer: new genes in confined pathways.

Authors:  Finn Cilius Nielsen; Thomas van Overeem Hansen; Claus Storgaard Sørensen
Journal:  Nat Rev Cancer       Date:  2016-08-12       Impact factor: 60.716

9.  The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection.

Authors:  David Billing; Michiko Horiguchi; Foon Wu-Baer; Angelo Taglialatela; Giuseppe Leuzzi; Silvia Alvarez Nanez; Wenxia Jiang; Shan Zha; Matthias Szabolcs; Chyuan-Sheng Lin; Alberto Ciccia; Richard Baer
Journal:  Mol Cell       Date:  2018-09-20       Impact factor: 17.970

10.  SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.

Authors:  Elizabeth V Minten; Priya Kapoor-Vazirani; Chunyang Li; Hui Zhang; Kamakshi Balakrishnan; David S Yu
Journal:  Cell Rep       Date:  2021-03-30       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.